Longitudinal studies of the 18F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT

被引:0
|
作者
Christos Sachpekidis
Hoda Anwar
Julia K. Winkler
Annette Kopp-Schneider
Lionel Larribere
Uwe Haberkorn
Jessica C. Hassel
Antonia Dimitrakopoulou-Strauss
机构
[1] German Cancer Research Center (DKFZ),Clinical Cooperation Unit Nuclear Medicine
[2] University of Heidelberg,Department of Dermatology and National Center for Tumor Diseases
[3] German Cancer Research Center (DKFZ),Department of Biostatistics
[4] German Cancer Research Center (DKFZ),Skin Cancer Unit
[5] University of Heidelberg,Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim
[6] University of Heidelberg,Division of Nuclear Medicine
来源
关键词
Metastatic melanoma; Ipilimumab; F-FDG PET/CT; PERCIMT criteria;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1261 / 1270
页数:9
相关论文
共 50 条
  • [1] Longitudinal studies of the 18F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT
    Sachpekidis, Christos
    Anwar, Hoda
    Winkler, Julia K.
    Kopp-Schneider, Annette
    Larribere, Lionel
    Haberkorn, Uwe
    Hassel, Jessica C.
    Dimitrakopoulou-Strauss, Antonia
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (08) : 1261 - 1270
  • [2] 18F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma
    Ito, Kimiteru
    Teng, Rebecca
    Schoder, Heiko
    Humm, John L.
    Ni, Ai
    Michaud, Laure
    Nakajima, Reiko
    Yamashita, Rikiya
    Wolchok, Jedd D.
    Weber, Wolfgang A.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (03) : 335 - 341
  • [3] 18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab
    Sachpekidis, C.
    Kopp-Schneider, A.
    Hakim-Meibodi, L.
    Hassel, J.
    Dimitrakopoulou-Strauss, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S517 - S517
  • [4] 18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab
    Sachpekidis, Christos
    Kopp-Schneider, Annette
    Hakim-Meibodi, Lara
    Dimitrakopoulou-Strauss, Antonia
    Hassel, Jessica C.
    [J]. MELANOMA RESEARCH, 2019, 29 (02) : 178 - 186
  • [5] The predictive value of 18F-FDG PET/CT after ipilimumab for treatment response evaluation in metastatic melanoma patients
    Vari, S.
    Annovazzi, A.
    Pasqualoni, R.
    Sciuto, R.
    Giannarelli, D.
    Cognetti, F.
    Ferraresi, V.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [6] The role of interim 18F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma
    Sachpekidis, Christos
    Anwar, Hoda
    Winkler, Julia
    Kopp-Schneider, Annette
    Larribere, Lionel
    Haberkorn, Uwe
    Hassel, Jessica C.
    Dimitrakopoulou-Strauss, Antonia
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (08) : 1289 - 1296
  • [7] The role of interim 18F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma
    Christos Sachpekidis
    Hoda Anwar
    Julia Winkler
    Annette Kopp-Schneider
    Lionel Larribere
    Uwe Haberkorn
    Jessica C. Hassel
    Antonia Dimitrakopoulou-Strauss
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 1289 - 1296
  • [8] Prognostic value of post-treatment 18F-FDG PET/CT studies in melanoma patients receiving ipilimumab
    Anwar, Hoda
    Sachpekidis, Christos
    Winkler, Julia
    Hassel, Jessica
    Haberkorn, Uwe
    Dimitrakopoulou-Strauss, Antonia
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [9] 18F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma
    Annie Wong
    Jason Callahan
    Marleen Keyaerts
    Bart Neyns
    Johanna Mangana
    Susanne Aberle
    Alan Herschtal
    Sonia Fullerton
    Donna Milne
    Amir Iravani
    Grant A. McArthur
    Rodney J. Hicks
    [J]. Cancer Imaging, 20
  • [10] 18F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma
    Wong, Annie
    Callahan, Jason
    Keyaerts, Marleen
    Neyns, Bart
    Mangana, Johanna
    Aberle, Susanne
    Herschtal, Alan
    Fullerton, Sonia
    Milne, Donna
    Iravani, Amir
    McArthur, Grant A.
    Hicks, Rodney J.
    [J]. CANCER IMAGING, 2020, 20 (01)